Efficacy and Safety of a Once Daily Regimen with Efavirenz, Lamivudine, and Didanosine, with and without Food, as Initial Therapy for HIV Infection: The ELADI Study

Matilde Sánchez-Conde; Rosario Palacios; José Sanz; Sonia Rodríguez-Novoa; Pablo Rivas; Jesús Santos; Julio Sola; Victor Asensi; Carmen de Mendoza; Vicente Estrada; Pablo Barreiro; Juan González-Lahoz; Inmaculada Jiménez-Nacher; Vincent Soriano

doi:10.1089/aid.2006.0029

Efficacy and Safety of a Once Daily Regimen with Efavirenz, Lamivudine, and Didanosine, with and without Food, as Initial Therapy for HIV Infection: The ELADI Study

AIDS Research and Human Retroviruses ◽

10.1089/aid.2006.0029 ◽

2007 ◽

Vol 23 (10) ◽

pp. 1237-1241 ◽

Cited By ~ 8

Author(s):

Matilde Sánchez-Conde ◽

Rosario Palacios ◽

José Sanz ◽

Sonia Rodríguez-Novoa ◽

Pablo Rivas ◽

...

Keyword(s):

Hiv Infection ◽

Initial Therapy ◽

Daily Regimen ◽

Efficacy And Safety ◽

Once Daily

Download Full-text

A Proof‐of‐Concept Study of Short‐Cycle Intermittent Antiretroviral Therapy with a Once‐Daily Regimen of Didanosine, Lamivudine, and Efavirenz for the Treatment of Chronic HIV Infection

The Journal of Infectious Diseases ◽

10.1086/386344 ◽

2004 ◽

Vol 189 (11) ◽

pp. 1974-1982 ◽

Cited By ~ 41

Author(s):

Mark Dybul ◽

Elizabeth Nies‐Kraske ◽

Robin Dewar ◽

Frank Maldarelli ◽

Claire W. Hallahan ◽

...

Keyword(s):

Antiretroviral Therapy ◽

Hiv Infection ◽

Daily Regimen ◽

Proof Of Concept ◽

Once Daily ◽

Short Cycle ◽

Concept Study ◽

Chronic Hiv Infection

Download Full-text

Ofloxacin in the treatment of acute exacerbations of chronic bronchitis: Efficacy and safety of a once-daily regimen

Current Therapeutic Research ◽

10.1016/s0011-393x(05)80626-5 ◽

1993 ◽

Vol 54 (3) ◽

pp. 265-271 ◽

Cited By ~ 3

Author(s):

J.R. T'Jonck ◽

F.T.C. Willems

Keyword(s):

Chronic Bronchitis ◽

Daily Regimen ◽

Efficacy And Safety ◽

Once Daily ◽

Acute Exacerbations

Download Full-text

Efficacy and Safety of Once-Daily Regimens in the Treatment of HIV Infection

Drugs ◽

10.2165/00003495-200868050-00001 ◽

2008 ◽

Vol 68 (5) ◽

pp. 567-578 ◽

Cited By ~ 33

Author(s):

Jean-Michel Molina

Keyword(s):

Hiv Infection ◽

Efficacy And Safety ◽

Once Daily

Download Full-text

Efficacy and Safety of Once-daily Tiotropium Respimat®Add-on Therapy over 1 Year in Adolescent Patients with Moderate Symptomatic Asthma

PEDIATRICS ◽

10.1542/peds.137.supplement_3.203a ◽

2016 ◽

Vol 137 (Supplement 3) ◽

pp. 203A-203A

Author(s):

Lyndon Mansfield ◽

Petra Moroni-Zentgraf ◽

Michael Engel ◽

Mandy Avis ◽

Reinhold Lühmann ◽

...

Keyword(s):

Efficacy And Safety ◽

Once Daily ◽

Adolescent Patients ◽

Symptomatic Asthma

Download Full-text

A review of the efficacy and safety of once-daily tiotropium Respimat 2.5 micrograms in adults and adolescents with asthma

Allergy and Asthma Proceedings ◽

10.2500/aap.2017.38.1403 ◽

2017 ◽

Author(s):

E.O. Meltzer ◽

W. E. Berger

Keyword(s):

Efficacy And Safety ◽

Once Daily

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of the coadministration of tadalafil once daily with finasteride for 6 months in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718133721.793486562 ◽

2013 ◽

Author(s):

Francisco Cruz

Keyword(s):

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Lower Urinary Tract Symptoms ◽

Lower Urinary Tract ◽

Prostatic Hyperplasia ◽

Efficacy And Safety ◽

Once Daily ◽

Urinary Tract Symptoms ◽

Prostatic Enlargement ◽

Lower Urinary

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of olodaterol once daily delivered via Respimat® in patients with GOLD 2-4 COPD: results from two replicate 48-week studies.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725527998.793532738 ◽

2017 ◽

Author(s):

Ravi Kalhan ◽

Sharon R Rosenberg

Keyword(s):

Efficacy And Safety ◽

Once Daily

Download Full-text

Efficacy and safety of once-daily, single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol in Japanese patients with inadequately controlled asthma: the CAPTAIN study

Current Medical Research and Opinion ◽

10.1080/03007995.2021.1944849 ◽

2021 ◽

pp. 1-1

Author(s):

Yoichi Nakamura ◽

Soichiro Hozawa ◽

Hironori Sagara ◽

Hiroyuki Ohbayashi ◽

Laurie A. Lee ◽

...

Keyword(s):

Japanese Patients ◽

Efficacy And Safety ◽

Fluticasone Furoate ◽

Once Daily

Download Full-text

Randomised clinical trial: a multicentre, double-blind, placebo-controlled study on the efficacy and safety of rabeprazole 5 mg or 10 mg once daily in patients with non-erosive reflux disease

Alimentary Pharmacology & Therapeutics ◽

10.1111/j.1365-2036.2010.04508.x ◽

2010 ◽

Vol 33 (2) ◽

pp. 213-224 ◽

Cited By ~ 22

Author(s):

Y. Kinoshita ◽

K. Ashida ◽

M. Hongo ◽

Keyword(s):

Clinical Trial ◽

Reflux Disease ◽

Randomised Clinical Trial ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Once Daily ◽

Double Blind Placebo

Download Full-text

Efficacy and safety of once-daily monotherapy with coat-core nisoldipine in patients with stable angina pectoris: Dose response studies

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(96)80750-9 ◽

1996 ◽

Vol 27 (2) ◽

pp. 131

Author(s):

Udho Thadani

Keyword(s):

Angina Pectoris ◽

Dose Response ◽

Stable Angina ◽

Efficacy And Safety ◽

Stable Angina Pectoris ◽

Once Daily

Download Full-text